WO2008030818A3 - Novel liposome compositions - Google Patents

Novel liposome compositions Download PDF

Info

Publication number
WO2008030818A3
WO2008030818A3 PCT/US2007/077548 US2007077548W WO2008030818A3 WO 2008030818 A3 WO2008030818 A3 WO 2008030818A3 US 2007077548 W US2007077548 W US 2007077548W WO 2008030818 A3 WO2008030818 A3 WO 2008030818A3
Authority
WO
WIPO (PCT)
Prior art keywords
liposome compositions
novel liposome
containing compositions
lipid
targeted liposomes
Prior art date
Application number
PCT/US2007/077548
Other languages
French (fr)
Other versions
WO2008030818A2 (en
Inventor
Yusuke Miyajima
Kazushi Okada
Naoyuki Morisaki
Original Assignee
Mebiopharm Co Ltd
Yusuke Miyajima
Kazushi Okada
Naoyuki Morisaki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mebiopharm Co Ltd, Yusuke Miyajima, Kazushi Okada, Naoyuki Morisaki filed Critical Mebiopharm Co Ltd
Publication of WO2008030818A2 publication Critical patent/WO2008030818A2/en
Publication of WO2008030818A3 publication Critical patent/WO2008030818A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Abstract

The present disclosure provides lipid-containing compositions, including targeted liposomes encapsulating methotrexate, and pharmaceutical formulations thereof, as well as methods for the making and using the lipid-containing compositions, including the use of the targeted liposomes in the treatment of cancer, rheumatoid arthritis and other diseases.
PCT/US2007/077548 2006-09-05 2007-09-04 Novel liposome compositions WO2008030818A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84246706P 2006-09-05 2006-09-05
US60/842,467 2006-09-05
US90527007P 2007-03-05 2007-03-05
US60/905,270 2007-03-05

Publications (2)

Publication Number Publication Date
WO2008030818A2 WO2008030818A2 (en) 2008-03-13
WO2008030818A3 true WO2008030818A3 (en) 2008-06-05

Family

ID=39157979

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/077548 WO2008030818A2 (en) 2006-09-05 2007-09-04 Novel liposome compositions

Country Status (1)

Country Link
WO (1) WO2008030818A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7829113B2 (en) 2005-03-10 2010-11-09 Mebiopharm Co., Ltd. Liposome compositions

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9770414B2 (en) * 2010-05-13 2017-09-26 Pacira Pharmaceuticals, Inc. Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent
WO2012058483A1 (en) 2010-10-28 2012-05-03 Pacira Pharmaceuticals, Inc. A sustained release formulation of a non-steroidal anti-inflammatory drug
KR102302503B1 (en) 2012-07-05 2021-09-15 타이완 리포좀 캄파니 리미티드 Methods of treating arthritis
SG11201501010QA (en) 2012-08-10 2015-04-29 Taiho Pharmaceutical Co Ltd Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same
AU2017308158B2 (en) 2016-08-12 2023-08-10 L.E.A.F. Holdings Group Llc Alpha and gamma-D polyglutamated antifolates and uses thereof
EP3541815A4 (en) 2016-11-18 2020-07-15 Pacira Pharmaceuticals, Inc. Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same
CN115475142A (en) * 2017-11-20 2022-12-16 平顶山学院 Oral methotrexate liposome and preparation method thereof
CN111954531A (en) 2018-02-07 2020-11-17 L.E.A.F.控股集团公司 Alpha polyglutamated pemetrexed and its use
EP3749316A4 (en) 2018-02-07 2021-10-27 L.E.A.F Holdings Group LLC Alpha polyglutamated pralatrexate and uses thereof
WO2019160734A1 (en) 2018-02-14 2019-08-22 L.E.A.F. Holdings Group Llc Gamma polyglutamated lometrexol and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294191B1 (en) * 1996-10-15 2001-09-25 The Liposome Company, Inc. N-acyl phosphatidylethanolamine-mediated liposomal drug delivery

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294191B1 (en) * 1996-10-15 2001-09-25 The Liposome Company, Inc. N-acyl phosphatidylethanolamine-mediated liposomal drug delivery

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7829113B2 (en) 2005-03-10 2010-11-09 Mebiopharm Co., Ltd. Liposome compositions
US8758810B2 (en) 2005-03-10 2014-06-24 Mebiopharm Co., Ltd. Liposome compositions

Also Published As

Publication number Publication date
WO2008030818A2 (en) 2008-03-13

Similar Documents

Publication Publication Date Title
WO2006099169A3 (en) Novel liposome compositions
WO2008030818A3 (en) Novel liposome compositions
MX2007008790A (en) Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use.
WO2006131591A3 (en) An entacapone-containing oral dosage form
WO2008005705A3 (en) Metal-containing formulations and methods of use
WO2007064857A3 (en) Amphoteric liposome formulation
TW200716646A (en) (S)-N-methylnaltrexone
WO2012075383A3 (en) Bromodomain inhibitors and uses thereof
WO2007044950A3 (en) Crystalline forms of docetaxel and processes for their preparation
HK1124321A1 (en) Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
WO2009121039A3 (en) Administration of benzodiazepine compositions
WO2007025146A3 (en) Balsalazide formulations and manufacture and use thereof
CL2007002708A1 (en) COMPOUNDS DERIVED FROM PIRROLO [2,3-B] PIRIDINA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS CANCER, CAQUEXY, INFLAMMATORY DISORDERS, AMONG OTHERS.
WO2009135190A3 (en) Therapeutic calcium phosphate particles and methods of making and using same
WO2006029081A3 (en) Nucleoside-lipid conjugates, their method of preparation and uses thereof
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
WO2007105015A3 (en) DERIVATIVES OF 18ß-GLYCYRRHETINIC ACID
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
WO2008063808A3 (en) Encapsulated peptide amphiphile nanostructures
WO2008070141A3 (en) Compositions for delivery of therapeutic agents
WO2007022642A3 (en) Anti-inflammatory molecules and their uses
HK1120417A1 (en) Stable nanoparticle formulations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07814666

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07814666

Country of ref document: EP

Kind code of ref document: A2